Selected research
Industry Research
Contraceptive Devices Industry Research Report 2026
Market perspective
The global Contraceptive Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Contraceptive Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Contraceptive Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Contraceptive Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Contraceptive Devices include Actavis, Agile Therapeutics, Ansell, Caya, Church & Dwight, Condomi Health, HLL Lifecare, Karex Industries and Medicines360, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Contraceptive Devices market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Contraceptive Devices Market by Company
Actavis
Agile Therapeutics
Ansell
Caya
Church & Dwight
Condomi Health
HLL Lifecare
Karex Industries
Medicines360
Okamoto Industries
The Female Health Company
TodaySponge
Bayer
Merck & Co
Teva Pharmaceutical
Contraceptive Devices Segment by Type
Male Contraceptive Devices
Female Contraceptive Devices
Contraceptive Devices Segment by Application
E-Commerce
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Others
Contraceptive Devices Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Contraceptive Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Contraceptive Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Contraceptive Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Male Contraceptive Devices
- Female Contraceptive Devices
Applications
- E-Commerce
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
- Others
Companies covered
- Actavis
- Agile Therapeutics
- Ansell
- Caya
- Church & Dwight
- Condomi Health
- HLL Lifecare
- Karex Industries
- Medicines360
- Okamoto Industries
- The Female Health Company
- TodaySponge
- Bayer
- Merck & Co
- Teva Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Contraceptive Devices Market Size (2021-2032)
- 2.2.2 Global Contraceptive Devices Sales (2021-2032)
- 2.2.3 Global Contraceptive Devices Market Average Price (2021-2032)
- 2.3 Contraceptive Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Male Contraceptive Devices
- 2.3.3 Female Contraceptive Devices
- 2.4 Contraceptive Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 E-Commerce
- 2.4.3 Retail Pharmacy
- 2.4.4 Online Pharmacy
- 2.4.5 Hospital Pharmacy
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Contraceptive Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Contraceptive Devices Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Contraceptive Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Contraceptive Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Contraceptive Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Contraceptive Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Contraceptive Devices, Product Type & Application
- 3.8 Global Manufacturers of Contraceptive Devices, Established Date
- 3.9 Global Contraceptive Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Actavis
- 4.1.1 Actavis Company Information
- 4.1.2 Actavis Business Overview
- 4.1.3 Actavis Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Actavis Contraceptive Devices Product Portfolio
- 4.1.5 Actavis Recent Developments
- 4.2 Agile Therapeutics
- 4.2.1 Agile Therapeutics Company Information
- 4.2.2 Agile Therapeutics Business Overview
- 4.2.3 Agile Therapeutics Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Agile Therapeutics Contraceptive Devices Product Portfolio
- 4.2.5 Agile Therapeutics Recent Developments
- 4.3 Ansell
- 4.3.1 Ansell Company Information
- 4.3.2 Ansell Business Overview
- 4.3.3 Ansell Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ansell Contraceptive Devices Product Portfolio
- 4.3.5 Ansell Recent Developments
- 4.4 Caya
- 4.4.1 Caya Company Information
- 4.4.2 Caya Business Overview
- 4.4.3 Caya Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Caya Contraceptive Devices Product Portfolio
- 4.4.5 Caya Recent Developments
- 4.5 Church & Dwight
- 4.5.1 Church & Dwight Company Information
- 4.5.2 Church & Dwight Business Overview
- 4.5.3 Church & Dwight Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Church & Dwight Contraceptive Devices Product Portfolio
- 4.5.5 Church & Dwight Recent Developments
- 4.6 Condomi Health
- 4.6.1 Condomi Health Company Information
- 4.6.2 Condomi Health Business Overview
- 4.6.3 Condomi Health Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Condomi Health Contraceptive Devices Product Portfolio
- 4.6.5 Condomi Health Recent Developments
- 4.7 HLL Lifecare
- 4.7.1 HLL Lifecare Company Information
- 4.7.2 HLL Lifecare Business Overview
- 4.7.3 HLL Lifecare Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 HLL Lifecare Contraceptive Devices Product Portfolio
- 4.7.5 HLL Lifecare Recent Developments
- 4.8 Karex Industries
- 4.8.1 Karex Industries Company Information
- 4.8.2 Karex Industries Business Overview
- 4.8.3 Karex Industries Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Karex Industries Contraceptive Devices Product Portfolio
- 4.8.5 Karex Industries Recent Developments
- 4.9 Medicines360
- 4.9.1 Medicines360 Company Information
- 4.9.2 Medicines360 Business Overview
- 4.9.3 Medicines360 Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Medicines360 Contraceptive Devices Product Portfolio
- 4.9.5 Medicines360 Recent Developments
- 4.10 Okamoto Industries
- 4.10.1 Okamoto Industries Company Information
- 4.10.2 Okamoto Industries Business Overview
- 4.10.3 Okamoto Industries Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Okamoto Industries Contraceptive Devices Product Portfolio
- 4.10.5 Okamoto Industries Recent Developments
- 4.11 The Female Health Company
- 4.11.1 The Female Health Company Company Information
- 4.11.2 The Female Health Company Business Overview
- 4.11.3 The Female Health Company Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 The Female Health Company Contraceptive Devices Product Portfolio
- 4.11.5 The Female Health Company Recent Developments
- 4.12 TodaySponge
- 4.12.1 TodaySponge Company Information
- 4.12.2 TodaySponge Business Overview
- 4.12.3 TodaySponge Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 TodaySponge Contraceptive Devices Product Portfolio
- 4.12.5 TodaySponge Recent Developments
- 4.13 Bayer
- 4.13.1 Bayer Company Information
- 4.13.2 Bayer Business Overview
- 4.13.3 Bayer Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Bayer Contraceptive Devices Product Portfolio
- 4.13.5 Bayer Recent Developments
- 4.14 Merck & Co
- 4.14.1 Merck & Co Company Information
- 4.14.2 Merck & Co Business Overview
- 4.14.3 Merck & Co Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Merck & Co Contraceptive Devices Product Portfolio
- 4.14.5 Merck & Co Recent Developments
- 4.15 Teva Pharmaceutical
- 4.15.1 Teva Pharmaceutical Company Information
- 4.15.2 Teva Pharmaceutical Business Overview
- 4.15.3 Teva Pharmaceutical Contraceptive Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Teva Pharmaceutical Contraceptive Devices Product Portfolio
- 4.15.5 Teva Pharmaceutical Recent Developments
5 Global Contraceptive Devices Market Scenario by Region
- 5.1 Global Contraceptive Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Contraceptive Devices Sales by Region: 2021-2032
- 5.2.1 Global Contraceptive Devices Sales by Region: 2021-2026
- 5.2.2 Global Contraceptive Devices Sales by Region: 2027-2032
- 5.3 Global Contraceptive Devices Revenue by Region: 2021-2032
- 5.3.1 Global Contraceptive Devices Revenue by Region: 2021-2026
- 5.3.2 Global Contraceptive Devices Revenue by Region: 2027-2032
- 5.4 North America Contraceptive Devices Market Facts & Figures by Country
- 5.4.1 North America Contraceptive Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Contraceptive Devices Sales by Country (2021-2032)
- 5.4.3 North America Contraceptive Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Contraceptive Devices Market Facts & Figures by Country
- 5.5.1 Europe Contraceptive Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Contraceptive Devices Sales by Country (2021-2032)
- 5.5.3 Europe Contraceptive Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Contraceptive Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Contraceptive Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Contraceptive Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Contraceptive Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Contraceptive Devices Market Facts & Figures by Country
- 5.7.1 South America Contraceptive Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Contraceptive Devices Sales by Country (2021-2032)
- 5.7.3 South America Contraceptive Devices Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Contraceptive Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Contraceptive Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Contraceptive Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Contraceptive Devices Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Contraceptive Devices Sales by Type (2021-2032)
- 6.1.1 Global Contraceptive Devices Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Contraceptive Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Contraceptive Devices Revenue by Type (2021-2032)
- 6.2.1 Global Contraceptive Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Contraceptive Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Contraceptive Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Contraceptive Devices Sales by Application (2021-2032)
- 7.1.1 Global Contraceptive Devices Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Contraceptive Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Contraceptive Devices Revenue by Application (2021-2032)
- 7.2.1 Global Contraceptive Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Contraceptive Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Contraceptive Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Contraceptive Devices Value Chain Analysis
- 8.1.1 Contraceptive Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Contraceptive Devices Production Mode & Process
- 8.2 Contraceptive Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Contraceptive Devices Distributors
- 8.2.3 Contraceptive Devices Customers
9 Global Contraceptive Devices Analyzing Market Dynamics
- 9.1 Contraceptive Devices Industry Trends
- 9.2 Contraceptive Devices Industry Drivers
- 9.3 Contraceptive Devices Industry Opportunities and Challenges
- 9.4 Contraceptive Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst